[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @biotechsanya2 SSV SSV posts on X about $traw, $5byear, $15mil, $ifrx the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1715091835259887616/interactions)  - X Week XXXXX +2% - X Month XXXXX +2,675% - X Months XXXXX +9,792% - X Year XXXXX +943% ### Mentions: X [#](/creator/twitter::1715091835259887616/posts_active)  - X Week X +350% - X Month XX +1,200% - X Months XX +850% - X Year XX +950% ### Followers: XXX [#](/creator/twitter::1715091835259887616/followers)  - X Week XXX +24% - X Month XXX +152% - X Months XXX +739% ### CreatorRank: undefined [#](/creator/twitter::1715091835259887616/influencer_rank)  ### Social Influence [#](/creator/twitter::1715091835259887616/influence) --- **Social category influence** [currencies](/list/currencies) XX% [finance](/list/finance) XX% **Social topic influence** [$traw](/topic/$traw) 10%, [$5byear](/topic/$5byear) 10%, [$15mil](/topic/$15mil) 10%, [$ifrx](/topic/$ifrx) XX% **Top accounts mentioned or mentioned by** [@balabioresearch](/creator/undefined) [@streetcred2017](/creator/undefined) [@jeremyfalmouth](/creator/undefined) [@osprey172](/creator/undefined) [@biohazard3737](/creator/undefined) [@seedy19tron](/creator/undefined) [@kiefchief69](/creator/undefined) [@crocsanalyst](/creator/undefined) [@se19edy](/creator/undefined) ### Top Social Posts [#](/creator/twitter::1715091835259887616/posts) --- Top posts by engagements in the last XX hours "$TRAW seems like an obvious play at these levels: Binary P2a readout for TRX01 which has a $5b/year TAM in Covid-19 mcap at $15mil and strong PK data from P1. Target: $1326 if P2 is successful; also is a wonderful run-up play. Will publish full report soon on Substack. If they fail this likely goes to $XXXX Disclosure: Im long TRAW; no compensation; opinion only; see bio" [X Link](https://x.com/biotechsanya2/status/1975652886093635967) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-07T20:02Z XXX followers, 3818 engagements "$IFRX-- I *think* the main question is: did Avacopan fail because of insufficient blockade on of C5aR OR because C5aR s not rate-limiting If INF904 is a *better* Avacopan it DOESN'T matter if the reason why Ava' failed is that C5aR blockade doesn't achieve anything due to TNF-a signalling; other "Ils" is what drives signalling-- if the case is that C5aR blockade (IFRX thinks they have a more potent Ava') IS sufficient this COULD be a win. I think the odds of this working are minimal as we know that X C5a inhibitors have already failed that being said there's a small chance this hits as this" [X Link](https://x.com/biotechsanya2/status/1978587133511184878) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-15T22:21Z XXX followers, XXX engagements "@StreetCred2017 Yes I am referring to Avas failed HS trial. Also interesting they have never tested this in CSU despite sort of similar ideation therein and pathways etc" [X Link](https://x.com/biotechsanya2/status/1978589768918200775) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-15T22:32Z XXX followers, XXX engagements "@seedy19tron @KiefChief69 @CrocsAnalyst seedy is nktr a buyout candidate can you remind me pls also do they have a differentiated MoA Not sure about these parts. thx" [X Link](https://x.com/biotechsanya2/status/1980099579761524768) [@biotechsanya2](/creator/x/biotechsanya2) 2025-10-20T02:31Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SSV posts on X about $traw, $5byear, $15mil, $ifrx the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence currencies XX% finance XX%
Social topic influence $traw 10%, $5byear 10%, $15mil 10%, $ifrx XX%
Top accounts mentioned or mentioned by @balabioresearch @streetcred2017 @jeremyfalmouth @osprey172 @biohazard3737 @seedy19tron @kiefchief69 @crocsanalyst @se19edy
Top posts by engagements in the last XX hours
"$TRAW seems like an obvious play at these levels: Binary P2a readout for TRX01 which has a $5b/year TAM in Covid-19 mcap at $15mil and strong PK data from P1. Target: $1326 if P2 is successful; also is a wonderful run-up play. Will publish full report soon on Substack. If they fail this likely goes to $XXXX Disclosure: Im long TRAW; no compensation; opinion only; see bio"
X Link @biotechsanya2 2025-10-07T20:02Z XXX followers, 3818 engagements
"$IFRX-- I think the main question is: did Avacopan fail because of insufficient blockade on of C5aR OR because C5aR s not rate-limiting If INF904 is a better Avacopan it DOESN'T matter if the reason why Ava' failed is that C5aR blockade doesn't achieve anything due to TNF-a signalling; other "Ils" is what drives signalling-- if the case is that C5aR blockade (IFRX thinks they have a more potent Ava') IS sufficient this COULD be a win. I think the odds of this working are minimal as we know that X C5a inhibitors have already failed that being said there's a small chance this hits as this"
X Link @biotechsanya2 2025-10-15T22:21Z XXX followers, XXX engagements
"@StreetCred2017 Yes I am referring to Avas failed HS trial. Also interesting they have never tested this in CSU despite sort of similar ideation therein and pathways etc"
X Link @biotechsanya2 2025-10-15T22:32Z XXX followers, XXX engagements
"@seedy19tron @KiefChief69 @CrocsAnalyst seedy is nktr a buyout candidate can you remind me pls also do they have a differentiated MoA Not sure about these parts. thx"
X Link @biotechsanya2 2025-10-20T02:31Z XXX followers, XXX engagements
/creator/twitter::biotechsanya2